ResearcherUniversity of PittsburghNo recent work listed
Dwight Earl Heron
Matched on ORCID iD 0000-0001-6282-1806; OpenAlex author ID A5019997274. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 2, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 23
2012: 1 paper · 2013: 2 papers · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 3 papers · 2019: none · 2020: 1 paper · 2021: 1 paper
Papers 8
- Maximizing Tumor Control and Limiting Complications With Stereotactic Body Radiation Therapy for Pancreatic Cancer. Co-author DOI 10.1016/j.ijrobp.2020.11.017↗
- Patterns of Failure After Adjuvant Stereotactic Body Radiation Therapy for Pancreatic Cancer With Close or Positive Margins. Co-author DOI 10.1016/j.adro.2020.08.006↗
- Results of a prospective phase 2 clinical trial of induction gemcitabine/capecitabine followed by stereotactic ablative radiation therapy in borderline resecta… Last author DOI 10.1016/j.prro.2017.10.001↗
- Stereotactic Body Radiation Therapy for Locally Progressive and Recurrent Pancreatic Cancer after Prior Radiation. Last author DOI 10.3389/fonc.2018.00052↗
- Prognostic Factors for Elderly Patients Treated With Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma. Last author DOI 10.3389/fonc.2018.00282↗
- Stereotactic body radiotherapy in the treatment of pancreatic adenocarcinoma in elderly patients. Co-author DOI 10.1186/1748-717x-8-240↗
- Pathologic response with neoadjuvant chemotherapy and stereotactic body radiotherapy for borderline resectable and locally-advanced pancreatic cancer. First author DOI 10.1186/1748-717x-8-254↗
- Adjuvant stereotactic body radiotherapy for resected pancreatic adenocarcinoma with close or positive margins. First author DOI 10.1007/s12029-010-9203-7↗
Closest collaborators
The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Steven A. Burton · 6 shared papers, 2012–2020 · strength 0.40
- Paper Patterns of Failure After Adjuvant Stereotactic Body Radiation Therapy for Pancreatic Cancer With Close or Positive Mar… DOI 10.1016/j.adro.2020.08.006↗
- Paper Stereotactic Body Radiation Therapy for Locally Progressive and Recurrent Pancreatic Cancer after Prior Radiation. DOI 10.3389/fonc.2018.00052↗
- Paper Results of a prospective phase 2 clinical trial of induction gemcitabine/capecitabine followed by stereotactic ablative… DOI 10.1016/j.prro.2017.10.001↗
- Nathan Bahary · 5 shared papers, 2012–2020 · strength 0.36
- Paper Patterns of Failure After Adjuvant Stereotactic Body Radiation Therapy for Pancreatic Cancer With Close or Positive Mar… DOI 10.1016/j.adro.2020.08.006↗
- Paper Stereotactic Body Radiation Therapy for Locally Progressive and Recurrent Pancreatic Cancer after Prior Radiation. DOI 10.3389/fonc.2018.00052↗
- Paper Results of a prospective phase 2 clinical trial of induction gemcitabine/capecitabine followed by stereotactic ablative… DOI 10.1016/j.prro.2017.10.001↗
- Philip Anthony Sutera · 3 shared papers, 2018 · strength 0.29
- Paper Prognostic Factors for Elderly Patients Treated With Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma. DOI 10.3389/fonc.2018.00282↗
- Paper Stereotactic Body Radiation Therapy for Locally Progressive and Recurrent Pancreatic Cancer after Prior Radiation. DOI 10.3389/fonc.2018.00052↗
- Paper Results of a prospective phase 2 clinical trial of induction gemcitabine/capecitabine followed by stereotactic ablative… DOI 10.1016/j.prro.2017.10.001↗
- Herbert J. Zeh · 5 shared papers, 2012–2018 · strength 0.27
- Paper Stereotactic Body Radiation Therapy for Locally Progressive and Recurrent Pancreatic Cancer after Prior Radiation. DOI 10.3389/fonc.2018.00052↗
- Paper Results of a prospective phase 2 clinical trial of induction gemcitabine/capecitabine followed by stereotactic ablative… DOI 10.1016/j.prro.2017.10.001↗
- Paper Stereotactic body radiotherapy in the treatment of pancreatic adenocarcinoma in elderly patients. DOI 10.1186/1748-717x-8-240↗
- Rodney E. Wegner · 3 shared papers, 2013–2018 · strength 0.15
- Paper Results of a prospective phase 2 clinical trial of induction gemcitabine/capecitabine followed by stereotactic ablative… DOI 10.1016/j.prro.2017.10.001↗
- Paper Stereotactic body radiotherapy in the treatment of pancreatic adenocarcinoma in elderly patients. DOI 10.1186/1748-717x-8-240↗
- Paper Pathologic response with neoadjuvant chemotherapy and stereotactic body radiotherapy for borderline resectable and loca… DOI 10.1186/1748-717x-8-254↗
- Adam C. Olson · 1 shared paper, 2020 · strength 0.13
- Ankur Patel · 1 shared paper, 2020 · strength 0.13
- Amer H. Zureikat · 1 shared paper, 2020 · strength 0.13
- Simon Shek-Man Lo · 1 shared paper, 2021 · strength 0.12
- Karyn A. Goodman · 1 shared paper, 2021 · strength 0.12
- Manisha Palta · 1 shared paper, 2021 · strength 0.12
- Joseph M. Herman · 1 shared paper, 2021 · strength 0.12
- X. Allen Li · 1 shared paper, 2021 · strength 0.12
- Shalini Moningi · 1 shared paper, 2021 · strength 0.12
- Anand Mahadevan · 1 shared paper, 2021 · strength 0.12
- Amol Kumar Narang · 1 shared paper, 2021 · strength 0.12
- Kimmen Quan · 1 shared paper, 2018 · strength 0.08
- Arthur James Moser · 2 shared papers, 2013 · strength 0.07
- Carolyn H Kim · 1 shared paper, 2013 · strength 0.04
- Malolan Sri Rajagopalan · 1 shared paper, 2013 · strength 0.03
- Alyssa M. Krasinskas · 1 shared paper, 2013 · strength 0.03
- Randall E. Brand · 1 shared paper, 2013 · strength 0.03
- Jean-Claude M. Rwigema · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.